无创通气联合氨溴索雾化吸入治疗慢性阻塞性肺疾病合并呼吸衰竭的临床效果#br#

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (35 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical therapeutic effect of non-invasive ventilation combined with aerosol inhalation of Ambroxol on patients with chronic obstructive pulmonary disease and respiratory failure.Methods A hundred patients with chronic obstructive pulmonary disease and respiratory failure admitted to Iron Coal General Hospital of Liaoning Health Industry Group,Liaoning Province from January 2018 to December 2019 were selected as the research subjects.According to the random number table method,they were divided into two groups,with 50 cases in each group.In the control group,non-invasive ventilation adjuvant therapy was used,and in the study group,aerosol inhalation of Ambroxol on the basis of the control group was added.The clinical efficacy of the two groups was recorded,and the changes of related indexes(including heart rate[HR],respiratory rate[RR],blood oxygen saturation[SaO2],arterial oxygen partial pressure[PaO2])before and after treatment and the incidence of adverse reactions between the two groups were compared.Results After treatment,the HR and RR of the study group were(93.82±10.37)times/min and(22.07±1.89)times/min,both lower than those of the control group of(119.28±18.47)and(28.81±1.98)times/min,and the SaO2 of the study group was(99.0±4.8)%,PaO2 of the study group was(66.07±2.97)mmHg,both higher than(79.0±2.2)% and(51.12±2.11)mmHg in the control group,and the differences were statistically significant(P<0.05).The total effective rate of the study group was 96.0%,which was higher than that of the control group(76.0%),and the difference was statistically significant(P<0.05).The total incidence of adverse reactions in the study group was 12.0%,which was lower than 32.0% in the control group,and the difference was statistically significant(P<0.05).Conclusion Non-invasive ventilation combined with aerosol inhalation of Ambroxol therapy has a better clinical treatment effect for patients with chronic obstructive pulmonary disease and respiratory failure,and its safety is high,and it is worthy of widespread promotion.

Key words： Non-invasive ventilation Ambroxol Aerosol inhalation Chronic obstructive pulmonary disease with respiratory failure Clinical effect Effectiveness rate

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIN Da-yong

Cite this article:

LIN Da-yong. Clinical effect of non-invasive ventilation combined with aerosol inhalation of Ambroxol in the treatment of chronic obstructive pulmonary disease complicated with respiratory failure[J]. 中国当代医药, 2021, 28(18): 53-55转59.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I18/53

[1]	王丽思.慢性阻塞性肺部疾病合并呼吸衰竭患者应用肠内营养支持的疗效分析[J].中华养生保健，2020，38（3）：82-83.
[2]	王敏.氨溴索联合无创通气治疗慢性阻塞性肺疾病合并呼吸衰竭疗效分析[J].基层医学论坛，2020，24（8）：1106-1108.
[3]	刘佳春.分析无创通气治疗慢性阻塞性肺疾病合并呼吸衰竭的疗效[J].中国社区医师，2020，36（5）：74-75.
[4]	姜明花.盐酸氨溴索对慢性阻塞性肺疾病急性加重期的疗效分析[J].齐齐哈尔医学院学报，2019，40（13）：1616-1618.
[5]	岳龙.无创通气联合氨溴索雾化治疗慢阻肺合并呼吸衰竭疗效观察[J].蛇志，2017，29（4）：488-489.
[6]	李忠娥.无创通气联合氨溴索雾化治疗慢阻肺合并呼吸衰竭疗效观察[J].北方药学，2014，11（11）：58-59.
[7]	焦建华.无创通气联合氨溴索雾化治疗慢阻肺合并呼吸衰竭的应用效果分析[J].中国社区医师，2019，35（2）：22.
[8]	王丽丽.BiPAP 无创呼吸机治疗慢阻肺合并Ⅱ型呼吸衰竭临床效果观察[J].中国实用医药，2020，15（5）：40-42.
[9]	左小莉.BiPAP 无创呼吸机治疗慢阻肺合并Ⅱ型呼吸衰竭的临床观察[J].中国医疗器械信息，2020，26（6）：9-10.
[10]	吴永润，吴智锋.用盐酸氨溴索对老年慢性阻塞性肺疾病并发肺部感染患者进行治疗的效果分析[J].当代医药论丛，2020，18（4）：159-160.
[11]	赵永强，吴艳.盐酸氨溴索治疗慢性阻塞性肺疾病合并肺部感染的效果评估[J].医药前沿，2019，9（29）：144-145.
[12]	付凌寒，原许强.盐酸氨溴索联合无创通气治疗慢性阻塞性肺疾病合并呼吸衰竭的效果观察[J].中国药物与临床，2020，20（3）：453-454.
[13]	金晶雪.经面罩无创通气治疗慢性阻塞性肺疾病合并呼吸衰竭的疗效观察[J].中国医疗器械信息，2020，26（5）：112-113.
[14]	熊丽华.盐酸氨溴索治疗慢性阻塞性肺疾病合并肺部感染的临床效果观察[J].基层医学论坛，2020，24（8）：1057-1059.
[15]	周永辉.盐酸氨溴索治疗慢性阻塞性肺疾病合并肺部感染的临床效果观察[J].吉林医学，2020，41（4）：882-883.